» Articles » PMID: 7867749

Loss of Developing Cholinergic Basal Forebrain Neurons Following Excitotoxic Lesions of the Hippocampus: Rescue by Neurotrophins

Overview
Journal Exp Neurol
Specialty Neurology
Date 1994 Dec 1
PMID 7867749
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have demonstrated that the viability of developing cholinergic basal forebrain neurons is dependent upon the integrity of neurotrophin-secreting target cells. In the present study, we examined whether infusions of nerve growth factor (NGF) or brain-derived neurotrophic factor (BDNF) could prevent the loss of cholinergic septal/diagonal band neurons following excitotoxic lesions of their target neurons within the hippocampus. Postnatal Day 10 rat pups received unilateral intrahippocampal injections of ibotenic acid. Rats then received intracerebroventricular (icv) injections of nerve growth factor (30 micrograms/injection), brain-derived neurotrophic factor (60 micrograms/injection), or saline immediately following the lesion and continuing every third day for 27 days. Both saline- and BNDF-treated rats displayed a significant loss of septal/diagonal band neurons expressing the protein and mRNA for choline acetyltransferase (ChAT) and p75 low-affinity nerve growth factor receptor ipsilateral to the lesion. The magnitude of this loss was significantly attenuated in BNDF-treated rats. Many remaining neurons were atrophic with stunted dendritic processes. In contrast, NGF treatment completely rescued these cells and prevented the shrinkage of remaining cholinergic septal neurons. In addition, both NGF and BDNF induced a sprouting of cholinergic processes within the residual hippocampal remnant ipsilateral to the infusions. The present study demonstrates that icv injections of NGF, and to a lesser extent BDNF, prevent the loss of developing basal forebrain neurons which occurs following removal of normal target cells. Diffusion studies revealed relatively poor penetration of BDNF into brain parenchyma.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

The Neurotrophin System in the Postnatal Brain-An Introduction.

von Bohlen Und Halbach O, Klausch M Biology (Basel). 2024; 13(8).

PMID: 39194496 PMC: 11352095. DOI: 10.3390/biology13080558.


7, 8-Dihydroxyflavone, a TrkB receptor agonist, provides minimal protection against retinal vascular damage during oxygen-induced ischemic retinopathy.

Zaitoun I, Song Y, Suscha A, El Ragaby M, Sorenson C, Sheibani N PLoS One. 2021; 16(12):e0260793.

PMID: 34855884 PMC: 8638941. DOI: 10.1371/journal.pone.0260793.


Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease.

Wang S, Yao H, Xu Y, Hao R, Zhang W, Liu H Theranostics. 2020; 10(15):6854-6874.

PMID: 32550908 PMC: 7295064. DOI: 10.7150/thno.44165.


Human Neural Stem Cells Encoding ChAT Gene Restore Cognitive Function via Acetylcholine Synthesis, Aβ Elimination, and Neuroregeneration in APPswe/PS1dE9 Mice.

Park D, Choi E, Cho T, Joo S, Kim Y Int J Mol Sci. 2020; 21(11).

PMID: 32486466 PMC: 7313059. DOI: 10.3390/ijms21113958.


A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression.

Chen C, Dong Y, Liu F, Gao C, Ji C, Dang Y Neuropsychiatr Dis Treat. 2020; 16:637-649.

PMID: 32184603 PMC: 7061423. DOI: 10.2147/NDT.S227598.